By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

The National Institutes of Health’s sweeping cuts of grants that fund scientific research are inflicting pain almost universally across the U.S., including in most states that backed President Donald ...

The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its other GLP-1 products.

The juries for the 2025 Cannes Lions International Festival of Creativity were announced Thursday morning, with 10 healthcare leaders judging the Health & Wellness Lions and 10 judging the Pharma ...

Some of Kennedy’s allies say he’s become almost inaccessible since his confirmation and complain that he’s made glacial progress advancing MAHA goals, such as halting mRNA-based COVID shots and ...

Real Chemistry, a 2024 MM+M Agency 100 honoree, appointed Cali Howitt, PhD, as president of U.S. medical and executive leader for its promotional and medical affairs business in the U.S. General ...

Actress and patient advocate Selma Blair will be joining the 2025 HealthFront to discuss living with MS. Blair, who was first diagnosed with the disease in 2018, has become a leading advocate for the ...

Recent federal funding and staffing cuts undermine the future of the 988 program and threaten to erase progress made in Indiana and elsewhere, mental health advocates said.

The Trump administration made a decidedly pro-industry statement on the Inflation Reduction Act (IRA). In an executive order issued Tuesday, President Donald Trump outlined changes to the Biden ...

Arthur Sadoun has said Publicis Groupe is in a “strong” position for the rest of the year, thanks to an estimated $2 billion of new client wins in Q1, despite the fact that he conceded some clients ...

FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication ...

Omnicom reported revenue of $3.7 billion for the first quarter of 2025 and still expects to close its acquisition of Interpublic in the second half of the year. But profits were down.